Werewolf Therapeutics Inc (HOWL) Annual Income Statement (USD)
HOWL Quarterly Financials (USD)
Frequently Asked Questions About Werewolf Therapeutics Inc (HOWL) Stock
Werewolf Therapeutics Inc's (HOWL) last reported annual revenue was USD 19.94 Million.
Werewolf Therapeutics Inc's (HOWL) annual revenue growth rate based on the revenue reported in the past 5 years is : -38.97%
Werewolf Therapeutics Inc's(HOWL) is not profitable as of its last reported annual financials.
The net profit margin for Werewolf Therapeutics Inc's(HOWL) from its laster reported year is -187.37%
The return on equity (ROE) for Werewolf Therapeutics Inc's(HOWL) from its last reported annual financials is : -61.56%
The return on assets (ROA) for Werewolf Therapeutics Inc's(HOWL) from its last reported annual financials is : -26.16%
The return on invested capital (ROIC) for Werewolf Therapeutics Inc's(HOWL) from its last reported annual financials is : -30.84%
The Debt to Equity ratio for Werewolf Therapeutics Inc's(HOWL) from its last reported annual financials is : 29.32%
The dividend yield for Werewolf Therapeutics Inc's(HOWL) from its laster reported year is 0.00%
Werewolf Therapeutics Inc's(HOWL) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for HOWL !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
